Larimar Therapeutics, Inc. - COM (LRMR)

Historical Portfolio Holders from Q2 2020 to Q4 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
64.3M
Holdings value Q3 2024
$421M
Value change Q3 2024
-$5.93M
Grand Portfolio weight change Q3 2024
0%
Number of holders
122
Number of buys Q3 2024
0
Number of sells Q3 2024
-1
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$288 0
2024 Q3 64.3M $421M -$5.93M $6.55 122
2024 Q2 65.3M $473M +$12.2M $7.25 105
2024 Q1 63.6M $483M +$183M $7.59 104
2023 Q4 39.5M $180M +$15.2M $4.55 69
2023 Q3 38.7M $153M -$3.46M $3.95 64
2023 Q2 39M $120M -$3.77M $3.13 65
2023 Q1 38.5M $174M +$1.09M $4.53 68
2022 Q4 38.8M $160M +$976K $4.13 47
2022 Q3 38.7M $124M +$77.8M $3.20 52
2022 Q2 14.4M $28.2M -$2.24M $1.96 34
2022 Q1 15.3M $61.8M -$2.58M $4.05 40
2021 Q4 14.6M $157M +$628K $10.79 47
2021 Q3 14.4M $166M -$884K $11.53 50
2021 Q2 14.5M $143M -$4.48M $9.82 43
2021 Q1 14.1M $206M -$8.29M $14.61 53
2020 Q4 14.3M $305M +$10.4M $21.41 42
2020 Q3 13.6M $207M +$10.4M $15.17 37
2020 Q2 13M $166M +$166M $12.85 34